Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine
Status: Currently in Shortage
»Date first posted:
02/22/2012
»Therapeutic Categories: Anesthesia; Pediatric
Fresenius Kabi USA (Revised 05/31/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Xylocaine 1% w/EPI 10 mL, 100 mg MDV (NDC 63323-482-17) | Backordered. Next release June 2023. | Check wholesalers for inventory. | Manufacturing delay |
| Xylocaine 1% w/EPI 10 mL, 100 mg SDV, MPF (NDC 63323-487-17) | Backordered. Next release not available at this time. | Manufacturing delay | |
| Xylocaine 1.5% w/EPI 10 mL, 150 mg, SDV, MPF (NDC 63323-488-17) | Backordered. Next release not available at this time. | Check wholesalers for inventory. | Manufacturing delay |
| Xylocaine 2% w/EPI 10 mL, 200 mg, SDV, MPF (NDC 63323-489-17) | Backordered. Next release not available at this time. | Check wholesalers for inventory. | Manufacturing delay |
| Xylocaine 0.5% w/EPI 10 mL, 10 mg MDV (NDC 63323-481-57) | Backordered. Next release June 2023. | ||
| Xylocaine 1% w/EPI 20 mL, 200 mg MDV (NDC 63323-482-27) | Backordered. Next release June 2023. | Check wholesalers for inventory. | Demand increase for the drug |
| Xylocaine 1% w/EPI 50 mL, 500 mg MDV (NDC 63323-482-57) | Backordered. Next release June 2023. | ||
| Xylocaine 2% w/EPI 20 mL, 400 mg MDV (NDC 63323-483-27) | Backordered. Next release June 2023. | Check wholesalers for inventory. | Demand increase for the drug |
| Xylocaine 2% w/EPI 50 mL, 1 g MDV (NDC 63323-483-57) | Backordered. Next release June 2023. | Demand increase for the drug | |
| Xylocaine 1% w/EPI 30 mL, 300 mg, SDV MPF (NDC 63323-487-37) | Backordered. Next release June 2023. | Check wholesalers for inventory. | Demand increase for the drug |
| Xylocaine 1.5% w/EPI 30 mL, 450 mg, SDV, MPF (NDC 63323-488-37) | Backordered. Next release not available at this time. | Demand increase for the drug | |
| Xylocaine 2% w/EPI 20 ml, 400 mg SDV, MPF (NDC 63323-489-27) | Backordered. Next release June 2023. |
Hospira, Inc., a Pfizer company (Revised 05/15/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2.5 g/50 mL (0.5%; 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3177-01) | Limited Supply Available. Next Delivery: June 2023; Estimated Recovery: March 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 200 mg/20 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-01) | Next Delivery: November 2023; Estimated Recovery: September 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 300 mg/30 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-02) | Next Delivery: January 2024; Estimated Recovery: September 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 500 mg/50 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3178-03) | Next Delivery: October 2023; Estimated Recovery: September 2024 | Demand increase for the drug | |
| 75 mg/5 mL (1.5%; 1:200,000); Glass Ampul (NDC 0409-1209-01) | Next Delivery: July 2024; Estimated Recovery: September 2024 | Other | |
| 450 mg/30 mL (1.5%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3181-01) | Next Delivery and Estimated Recovery: December 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 400 mg/20 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-01) | Next Delivery: May 2023; Estimated Recovery: December 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 600 mg/30 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-02) | Next Delivery: November 2023; Estimated Recovery: September 2024 | Demand increase for the drug | |
| 1 g/50 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-03) | Next Delivery: June 2023; Estimated Recovery: September 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |
| 400 mg/20 mL (2%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3183-01) | Next Delivery: August 2023; Estimated Recovery: December 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Other |